Alternatives to Signadori Bio
Signadori Bio is a Biotechnology tool: developing a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to Signadori Bio
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
Kite Pharma66BiotechnologySanta Monica, United States$421.2MBiotechnology company developing and commercializing cell therapies for cancer treatment.
- Website
BioNTech66BiotechnologyMainz, Germany$975.0MGlobal biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
- Website
Degron Therapeutics62BiotechnologySan Diego, USA$40.0MClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
- Website
Enterome60BiotechnologyParis, France$123.9MClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
- Website
Adcendo60BiotechnologyCopenhagen, Denmark$272.0MDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
- Website
CellCentric60BiotechnologyCambridge, United Kingdom$375.0MA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
- Website
Infinimmune60BiotechnologyAlameda, United States$75.0MDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
- Website
Janux Therapeutics57BiotechnologySan Diego, USA$181.0MA clinical-stage biopharmaceutical company developing novel immunotherapies.
- EAEarendil Labs56BiotechnologyBeijing, China$787.0M
Earendil Labs is an AI biotechnology company focused on leveraging artificial intelligence for drug discovery and development of next-generation biologics.
- Website
Pixelgen Technologies62BiotechnologyStockholm, Sweden$43.5MA life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
- Website CRCrossbow Therapeutics55BiotechnologyCambridge, United States$157.0M
Developing TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes.
- Website
Cellares54BiotechnologySouth San Francisco, USA$327.0MThe first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.
- Website
Waypoint Bio53BiotechnologyNew York, USA$20.0MAI-native biotech company designing next-generation CAR T therapies for solid tumors.
- Website
Immix Biopharma, Inc.51BiotechnologyLos Angeles, United States$5.0MA clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.
- Website
ONCOMATRYX50BiotechnologyDerio, Spain$106.8MDeveloping Quantum ADCs against the tumor microenvironment for innovative cancer therapies.
- Website
Cartography Biosciences49BiotechnologySouth San Francisco, USA$150.0MA biotechnology company focused on oncology drug discovery.
- Website
LTZ Therapeutics49BiotechnologyRedwood City, USA$76.0MImmunotherapy company targeting oncology and autoimmune diseases.
- Website
Brenus Pharma48BiotechnologyLyon, France$12.6MClinical-stage immunotherapy company developing novel treatments for cancer.
- Website GEGenexine47BiotechnologySeoul, South Korea$296.5M
South Korean biopharmaceutical company developing novel biologics for cancer and rare diseases.
Showing the 20 closest matches. See the rest on the Signadori Bio profile.
Compare Signadori Bio head to head
Side by side on what each one does, what it costs, and what real users report.